Characterization of photon recycling in thin crystalline GaAs light emitting diodes

Gallium arsenide light emitting diodes (LEDs) were fabricated using molecular beam epitaxial films on GaAs substrates and removed by epitaxial lift-off (ELO). Lifted off devices were then mounted on a Si wafer using a Pd/Au/Cr contact layer, which also served as a back surface reflector. Devices were characterized by electrical and optical measurements, and the results for devices on the GaAs substrate were compared to those for EL0 devices. EL0 LEDs coated with a ZnS/MgF2 antireflection coating exhibited an optical output that was up to six times that of LEDs on GaAs substrates. At the same time, the measured current-voltage characteristics of the EL0 devices displayed a lower IZ = 1 current component. EL0 LEDs with efficiencies up to 12.5% were realized. We attribute these results to photon recycIing enhanced by the back-surface reflector in the EL0 LEDs. The luminescence versus current and current versus voltage characteristics of the LEDs were analyzed to obtain the nonradiative minority carrier lifetimes and the photon recycling factors. The results demonstrate that the measured characteristics are well described by photon recycling theory. EL0 LEDs may prove useful for characterizing recombination processes in LEDs, and thin-crystalline structures could provide substantial efficiency enhancements for LEDs and solar cells

Penetration Dynamics of Earth Penetration Warhead into Composite Target Media

Attempts have been made to develop a suitable computer code that can find solutions to the axi-symmetric penetration of an Earth Penetrating Warhead yielding complete space-time histories of the resistive force offered by the target medium. The consequent warhead deceleration and velocity reduction, the resulting axial compressive stress developed in warhead casing as the penetration process progresses into the composite target media consisting of hard concrete of specified thickness followed by earth soil have been discussed

Transistor-Based Studies of Heavy Dop-ing Effects in n-GaAs

The n2ieDp product (where n2ie is the np product and Dp is the minority hole mobility) in heavily doped n‐GaAs has been measured by electrical characterization of p‐n‐p GaAs homojunction transistors with base dopings ranging from approximately 1×1017 to 9×1018 cm−3. The measured n2ieDp product decreases as the doping density increases. These results suggest that nie is roughly constant with doping density, in sharp contrast to the large increase observed for p‐type GaAs. This work shows that when designing GaAs bipolar devices, it is important to consider the large difference in effective band gap between n+ and p+ regions

Very low resistance nonalloyed ohmic contacts using low-temperature molecular beam epitaxy of GaAs

Ex situ nonalloyed ohmic contacts were made to n- and p‐type GaAs using low‐temperature molecular beam epitaxy. For n‐type GaAs, Ag, and Ti/Au nonalloyed contacts displayed specific contact resistitivities of mid 10-7 ohm cm2. For p‐type GaAs, nonalloyed Ti/Au contacts with specific contact resistivities of about 10-7 ohm cm2 were obtained

Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer

Widespread health service goals to improve consistency and safety in patient care have prompted considerable investment in the development of evidence-based clinical guidelines. Computerised decision support (CDS) systems have been proposed as a means to implement guidelines in practice. This paper discusses the general concept in oncology and presents an evaluation of a CDS system to support triple assessment (TA) in breast cancer care. Balanced-block crossover experiment and questionnaire study. One stop clinic for symptomatic breast patients. Twenty-four practising breast clinicians from United Kingdom National Health Service hospitals. A web-based CDS system. Clinicians made significantly more deviations from guideline recommendations without decision support (60 out of 120 errors without CDS; 16 out of 120 errors with CDS, P<0.001). Ignoring minor deviations, 16 potentially critical errors arose in the no-decision-support arm of the trial compared with just one (P=0.001) when decision support was available. Opinions of participating clinicians towards the CDS tool became more positive after they had used it (P<0.025). The use of decision support capabilities in TA may yield significant measurable benefits for quality and safety of patient care. This is an important option for improving compliance with evidence-based practice guidelines

A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor

Treatment with TNFα inhibitors increases risk of reactivating a latent tuberculosis\infection (LTBI). Therefore screening, prior to therapy with TNFα inhibitors, has been recommended, even in low-endemic areas such as well-developed Western Europe countries. We evaluated interferon-gamma release assay (IGRA), as opposed to tuberculin skin test (TST), for detection of LTBI in refractory inflammatory disease patients prior to the initiation of a first TNFα inhibitor. In addition, we evaluated the impact of impaired cellular immunity on IGRA. Patients starting on TNFα inhibition were screened for LTBI by TST and IGRA (Quantiferon-TB Gold). Data on tuberculosis exposure and Bacillus Calmette–Guérin (BCG) vaccination were obtained. Cellular immunity was assessed by CD4+ T lymphocyte cell count. Nine out of 56 patients (16.1%) tested positive for LTBI. A concordant positive result was present in three patients with a medical history of tuberculosis exposure. Six patients with discordant test results had either: (1) a negative TST and positive IGRA in combination with a medical history of tuberculosis exposure (n = 1) or (2) a positive TST and negative IGRA in combination with BCG vaccination (n = 3) or a medical history of tuberculosis exposure (n = 2). CD4+ T lymphocyte cell counts were within normal limits, and no indeterminate results of IGRA were present. IGRA appears reliable for confirming TST and excluding a false positive TST (due to prior BCG vaccination) in this Dutch serie of patients. In addition, IGRA may detect one additional case of LTBI out of 56 patients that would otherwise be missed using solely TST. Immune suppression appears not to result significantly in lower CD4+ T lymphocyte cell counts and indeterminate results of IGRA, despite systemic corticosteroid treatment in half of the patients. Confirmation in larger studies, including assessment of cost-effectiveness, is required

Biochemical Characterization of a Structure-Specific Resolving Enzyme from Sulfolobus islandicus Rod-Shaped Virus 2

Sulfolobus islandicus rod shaped virus 2 (SIRV2) infects the archaeon Sulfolobus islandicus at extreme temperature (70°C–80°C) and acidity (pH 3). SIRV2 encodes a Holliday junction resolving enzyme (SIRV2 Hjr) that has been proposed as a key enzyme in SIRV2 genome replication. The molecular mechanism for SIRV2 Hjr four-way junction cleavage bias, minimal requirements for four-way junction cleavage, and substrate specificity were determined. SIRV2 Hjr cleaves four-way DNA junctions with a preference for cleavage of exchange strand pairs, in contrast to host-derived resolving enzymes, suggesting fundamental differences in substrate recognition and cleavage among closely related Sulfolobus resolving enzymes. Unlike other viral resolving enzymes, such as T4 endonuclease VII or T7 endonuclease I, that cleave branched DNA replication intermediates, SIRV2 Hjr cleavage is specific to four-way DNA junctions and inactive on other branched DNA molecules. In addition, a specific interaction was detected between SIRV2 Hjr and the SIRV2 virion body coat protein (SIRV2gp26). Based on this observation, a model is proposed linking SIRV2 Hjr genome resolution to viral particle assembly

NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus

The development of novel therapeutic agents is essential for combating the increasing number of cases of dengue fever in endemic countries and among a large number of travelers from non-endemic countries. The dengue virus has three structural proteins and seven non-structural (NS) proteins. NS3 is a multifunctional protein with an N-terminal protease domain (NS3pro) that is responsible for proteolytic processing of the viral polyprotein, and a C-terminal region that contains an RNA triphosphatase, RNA helicase and RNA-stimulated NTPase domain that are essential for RNA replication. The serine protease domain of NS3 plays a central role in the replicative cycle of dengue virus. This review discusses the recent structural and biological studies on the NS2B-NS3 protease-helicase and considers the prospects for the development of small molecules as antiviral drugs to target this fascinating, multifunctional protein